BRIEF-Vanc Pharma signs agreement for in-license on a CAD $150m generic molecule and soon to be off patent molecule

Mon Jun 20, 2016 8:43am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

June 20 (Reuters) - Vanc Pharmaceuticals Signs Definitive Agreement For Exclusive In

* Vanc pharmaceuticals says entered into definitive agreement for filing two ands with exclusive marketing rights to canada from an unnamed manufacturer

* Says other product will become off patent in 2017

* License on a cad $150m generic molecule and soon to be off patent molecule Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)